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The relevance of vaginal colonization of pregnant women by Escherichia coli is poorly
understood, despite these strains sharing a similar virulence profile with other extraintestinal
pathogenic E. coli producing severe obstetric and neonatal infections. We characterized the
epidemiology, antimicrobial susceptibility and virulence profiles of 84 vaginal E. coli isolates
from pregnant women from Rabat (Morocco) and Manhiça (Mozambique), two very distinct
epidemiological settings. Low levels of antimicrobial resistance were observed to all drugs
tested, except for trimethoprim-sulfamethoxazole in Manhiça, where this drug is extensively
used as prophylaxis for opportunistic HIV infections. The most prevalent virulence factors
were related to iron acquisition systems. Phylogroup A was the most common in Rabat,
while phylogroups E and non-typeable were the most frequent in Manhiça. Regardless of
the apparently “low virulence” of these isolates, the frequency of infections is higher and the
outcomes more devastating in constrained-resources conditions, especially among preg-
nant women and newborns.
Introduction
Most extraintestinal infections associated with Escherichia coli are caused by commensal strains
that become pathogenic by adaptation stratagems or the acquisition of virulence determinants
(Extraintestinal Pathogenic E. coli (ExPEC)) [1] and subsequently reach a particular sterile
body site [2]. Although vaginal E. coli (VEC) share a virulence profile with ExPEC [3], the pres-
ence of E. coli in the vagina has been poorly characterized, in contrast to other anatomic sites.
VEC isolates are able to cause several asymptomatic and symptomatic infections [4]. Further-
more, there is a clear link between E. coli forming part of the genital tract flora and those
PLOSONE | DOI:10.1371/journal.pone.0158695 July 7, 2016 1 / 10
a11111
OPEN ACCESS
Citation: Sáez-López E, Cossa A, Benmessaoud R,
Madrid L, Moraleda C, Villanueva S, et al. (2016)
Characterization of Vaginal Escherichia coli Isolated
from Pregnant Women in Two Different African Sites.
PLoS ONE 11(7): e0158695. doi:10.1371/journal.
pone.0158695
Editor: Marcia Edilaine Lopes Consolaro, State
University of Maringá/Universidade Estadual de
Maringá, BRAZIL
Received: April 21, 2016
Accepted: June 20, 2016
Published: July 7, 2016
Copyright: © 2016 Sáez-López et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All relevant data are
within the paper.
Funding: This study was supported by the Instituto
de Salud Carlos III under the grants CM13/00260,
CP11/00269, PI10/01579 and PI13/00127; the
European Directorate-General for Research and
Innovation Grant Agreement 612216; the Spanish
Agency of International Cooperation and
Development (AECID) 07-CO1-021. The funders had
no role in study design, data collection and analysis,
decision to publish, or preparation of the manuscript.
causing intra-amniotic infection [5], preterm premature rupture of membranes (PPROM) [6],
preterm delivery<34 weeks and the consequent neonatal outcomes, including very-low birth
weight newborns [7] and neonatal sepsis [3]. The prevalence of perinatal transmission of E. coli
during delivery ranges between 21 to 50% [8], being a clear predisposing factor to develop neo-
natal infections [9]. E. coli is the most frequent Gram-negative bacteria involved in neonatal
meningitis (45–64%) [10] and is the most common cause of stillbirth in developing countries
[11].
Antibiotic resistance varies from one geographical region to another [12]. However, the
high resistance of empiric antibiotherapy for different diseases is making increasingly difficult
to provide effective antibiotic treatment in Africa [12–14]. In addition, the number of multi-
drug-resistant strains is increasing, being extended spectrum β-lactamases (ESBLs) and carba-
penemases a matter of great concern [15–16].
Pertenance to B2 phylogenetic group and possession of virulence factors, such as adhesins,
iron acquisition systems, invasins and toxins have been associated with ExPEC causing obstet-
ric and perinatal complications [16–17]. Different distribution patterns have been described
according to geographic conditions, habits and host-associated factors [18].
The frequency and the consequences of infections transmitted from mother-to-child differ
according to the socio-economic conditions of each geographic area and are more common
and devastating in low-income countries with high exposure to infectious organisms, nutrient
deficiencies [9], low immune response [11], and limited access to health care services [10].
Therefore, it is important to characterize VEC isolates to determine their virulence potential
and ability to cause obstetric and neonatal infections.
This study was undertaken to determine the epidemiology, antimicrobial susceptibility and
virulence profiles of VEC isolates from pregnant women from two very different sites in Africa,
namely Rabat (Morocco, Northern Africa) and Manhiça (Mozambique, Southern Africa). The
rationale for recruiting in these two very distinct sites was to obtain a snapshot of the coloniza-
tion of pathogens among pregnant women under two very distinct epidemiological conditions,
not only in terms of circulating pathogens (with a very high HIV prevalence documented in
Manhiça, [19] and virtually no HIV in Rabat; and malaria being endemic in Manhiça but not
in Morocco [20]) but also in terms of antibiotic usage in those two settings [21].
Materials and Methods
Clinical sample collection and identification of E. coli isolates
The study included vaginal samples from pregnant women collected at theMaternité des Oran-
gers, in Rabat fromMarch to July 2013, and at the Hospital de Manhiça, in Manhiça from June
2014 to January 2015. Pregnant women were recruited within the framework of two projects:
(i) “Determining the epidemiology and risk factors for Group B Streptococcus and E.coli and
other bacterial infections among pregnant women and newborns in Rabat, Morocco
(EFRIMN)” and (ii) “Perinatal Group B Streptococcus, Escherichia coli and Pneumocystis jiro-
vecii infections in pregnant women and newborns in Manhiça, Mozambique (PIPAC)”. All
participating women signed a written informed consent prior to their inclusion in the study.
Protocols have been approved by the Ehical Committee of the Hospital Clinic of Barcelona, the
Ethical committee of the “Faculté de Médecine et Phamacie de l’Université Mohammed
V-Souissi” of Rabat and the Ethical Committee of the Centro de Investigação em Saúde de
Manhiça (CISM). Samples were collected at two different times, either (A) during the antenatal
control at 35 weeks of pregnancy and (B) or at delivery, regardless gestational age. All the
samples were spread onto MacConkey agar and incubated at 37°C overnight. The isolates were
Vaginal Escherichia coli in Morocco and Mozambique
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identified based on colony appearance, Gram stain and standard biochemical tests. Some iden-
tifications were confirmed by MALDI-TOF.
Antimicrobial resistance
Resistance profiles were determined using the standard Kirby-Bauer disk-diffusion method fol-
lowing CSLI guidelines [22]. The E. coli ATCC 25922 strain was used as the control. The anti-
microbial agents tested were ampicillin (AMP: 10 μg), amoxicillin/clavulanic acid (AMC:
30 μg), cefuroxime (CXM: 30 μg), cefotaxime (CTX: 30 μg), ceftazidime (CAZ: 30 μg), imipe-
nem (IPM: 10 μg), ertapenem (ETP: 10 μg), meropenem (MEM: 10 μg), tetracycline (TET:
30 μg), trimethoprim-sulfamethoxazole (SXT: 30μg), gentamicin (GEN: 10μg), nalidixic acid
(NAL: 30 μg), ciprofloxacin (CIP: 5 μg), chloramphenicol (CHL: 30 μg), aztreonam (AZT:
15 μg), piperacillin/tazobactam (TZP: 100/10 μg), fosfomycin (FOF: 200 μg), and colistin (CST:
10 μg). In addition, ESBLs were identified by the double-disk synergy test using CTX, AMC
and CAZ.
Prevalence of virulence factor genes (VFGs)
Thirteen virulence factor genes (VFGs) associated with ExPEC were detected by polymerase
chain reaction (PCR) using specific primers [23]. The genes studied included: hemolysin
(hlyA), cytotoxic necrotizing factor (cnf1), autotrasporter toxin (sat1), P- fimbriae (papA,
-EF, -C), type 1-C fimbriae (focG), heat-resistant hemagglutinin (hra), yersiniabactin
(fyuA), siderophores (iutA and iroN), aerobactin (iucC) and invasion of brain endothelium
factor (ibeA). PCR reactions were carried out under the following conditions: 94°C for 3
min, 25 cycles of denaturation at 94°C for 30 s, the corresponding annealing temperature
(55–63°) for 30 s, 72°C for 1 min and 30 s, and a final elongation at 72°C for 7 min. Samples
were run in 1.5% agarose gels and stained with Syber Safe. A 100 bp DNA ladder was used
in each gel as a molecular size marker and positive and negative control strains for the traits
were included.
Phylogenetic analysis
The new E. coli phylotyping method proposed by Clermont et al. [24] was used to classify the
strains into 8 groups (A, B1, B2, C, D, E, F, and Escherichia cryptic clade I). A few modifications
were made, including the use of a quadruplex-PCR instead of a simplex PCR method to deter-
mine the arpA, chuA, yjaA genes and the DNA fragment TspE4.C2. In addition, a primer con-
centration of 20 μMwas used and a simple PCR was performed for the second screening to
differentiate between group A or C and E or D, respectively.
Statistical analysis
Statistical analyses were performed using IBM SPSS Statistics software for Windows, version
20.0. We compared antibiotic resistance, the presence of VFGs and the phylogenetic groups of
all the isolates, considering a p-value below 0.05 as significant and p-values below 0.01 as statis-
tically significant. Categorical data were compared using the Chi-squared test and Yates' cor-
rection for continuity was applied to avoid overestimation of statistical significance when the
number of expected cases was between 3–5 in at least one group. When the number of expected
cases was below 3 in at least one group, the Fisher’s exact test was used.
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Results
Collection of bacterial isolates
A total of 33 VEC isolates (A = 18, B = 15) and 51 VEC isolates (A = 24, B = 27) were isolated
from pregnant women in Rabat and in Manhiça, respectively.
Antimicrobial resistance
All the isolates were screened for susceptibility to 17 antimicrobial agents (Fig 1). We classified
isolates showing intermediate levels of susceptibility as resistant. Susceptibility to all antimicro-
bial agents tested was seen in 22 isolates (67%) in Rabat and in 14 isolates (27%) in Manhiça,
with this difference being statistically significant (P = 0.001). Only one ESBL-producing E. coli
(harboring a CTX-M-15 enzyme) was found in one isolate fromManhiça. Frequency of resis-
tance to each of the antimicrobial agents studied, with the exception of CHL, was higher in
Manhiça compared to Rabat. The difference was statistically significantly only in the case of
the resistance to SXT (61% vs. 12% in Manhiça and Rabat, respectively, P< 0.0001). No signif-
icant differences were found between E. coli isolates from women belonging to group A or B.
Prevalence of VFGs
Remarkably, none of the virulence factors studied was encoded in 21% (7/33) of the strains
from Rabat compared with 43% (22/51) of those fromManhiça. The isolates from Rabat pre-
sented a higher frequency of VFGs than those from Manhiça, except for fyuA and ibeA, show-
ing statistical significance in the case of iutA (58 vs. 31%, P = 0.021), iucC (55 vs. 27%,
P = 0.024) and the hemolysin hlyA (21% vs. 2%, P = 0.005) (Table 1). In general, iron
Fig 1. Distribution of antimicrobial resistance among E. coli isolates from Rabat and Manhiça. AMP, ampicillin; AMC,
amoxicillin/clavulanic acid; CXM, cefuroxime, CTX, cefotaxime; CAZ, ceftazidime; IPM, imipenem; ETP, ertapenem; MEM,
meropenem; TET, tetracycline, SXT, trimethoprim/ sulfamethoxazole; GEN, gentamicin; NAL, nalidixic acid; CIP,
ciprofloxacin; CHL, chloramphenicol; AZM, azithromycin; TZP, piperacillin/tazobactam; FOF, fosfomycin, and CST, colistin.
(**P-value < 0.0001).
doi:10.1371/journal.pone.0158695.g001
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acquisition systems were the most frequent VFGs observed (iucC, 42%; fyuA, 40%; iutA, 38%),
while the cnf1 (2%), focG (2%) and ibeA (5%) genes were the least frequent. No statistically sig-
nificant differences were observed between groups A and B.
Phylogenetic analysis
Phylogenetic group A was the most common group among all the isolates from Rabat (14/33,
42%), whereas group E and non-typeable isolates were most frequently isolated in Manhiça
(15/51, 29% and 12/51, 23.5%, respectively) (Fig 2). Four (12%) and seven (14%) strains from
Table 1. Prevalence of virulence factor genes (VFGs) among E.coli isolates from Rabat and Manhiça.
Geographic area
VFGsa Rabat/Morocco n = 51 (%) Manhiça/Mozambique n = 33 (%) P-value
hlyA 7 (21) 1 (2) 0.005**
cnf1 2 (6) 0 0.151
sat1 10 (30) 10 (20) 0.301
papA 5 (15) 5 (10) 0.504
papEF 5 (15) 5 (10) 0.504
papC 6 (18) 6 (12) 0.526
focG 2 (6) 0 0.151
hra 10 (30) 7 (14) 0.095
fyuA 16 (48) 18 (35) 0.261
iutA 18 (55) 14 (27) 0.021*
iroN 5 (15) 4 (8) 0.306
iucC 19 (58) 16 (31) 0.024*
ibeA 1 (3) 3 (6) 1




Fig 2. Distribution of phylogenetic groups among E.coli isolates from Rabat and Manhiça.
doi:10.1371/journal.pone.0158695.g002
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Rabat and Manhiça, respectively, belonged to phylogroup B2. Phylogroups B1, D and E clade I
were identified in 12% of the remaining isolates from Rabat and phylogroups B1, D and F were
identified in 16% of those fromManhiça. No differences were found between groups A and B
in the two geographical areas.
Relationship between virulence factors, phylogenetic group and
antimicrobial resistance
No association was found between phylogroup B2 and VFGs. On the other hand, a statistically
significant relationship was observed between SXT-resistance and the presence of the sidero-
phores fyuA (P = 0.018) and iutA (P = 0.029) in Manhiça., Only in the case of ampicillin-resis-
tant isolates, the frequency of phylogroups B2 and D was higher than statistically expected
(18% vs. 13% and 18% vs. 5%, respectively).
Discussion
Pregnant women are more prone to develop different types of extraintestinal E. coli infections,
especially in the third trimester [14]. Host factors and the anatomic origin of the infection play
an important role in the severity of the disease [25]. Vagina and endocervix are reservoirs for
the colonization of E. coli strains and act favoring invasion of the amniotic fluid with the subse-
quent risk of neonatal infections [26]. There are few studies on the antimicrobial susceptibility
and/or virulence of E. coli isolates colonizing the genital tract of pregnant women [3],[23],[26–
27]. Moreover, to our knowledge no studies have been carried out to this respect in low or mid-
dle-income countries (LMICs), despite worse outcomes presented in these areas.
No differences in neither features studied were found between isolates from women attend-
ing antenatal clinics and those recruited during delivery, suggesting that sampling at delivery is
equally effective in terms of detecting pathogens (and defining their virulence profiles). No
changes seem to occur in terms of virulence profiles in infections acquired early or late during
pregnancy. Treating infections in LMICs adequately is challenging, because of the increasing
resistance to first line treatments. This is due to the extended use and misuse of antibiotics [14–
15],[28], the prohibitive costs in such settings of alternative choices such as cephalosporins
[29] and the limited antibiotic stock available in these areas [30]. Our isolates showed remark-
ably low antimicrobial resistance levels compared to ExPEC isolates from other studies carried
out in several African countries [14–15]. Notably, two thirds of the Moroccan (Rabat) isolates
from this series were completely susceptible. On the other hand, high resistance to SXT was
found in Manhiça, similar to the results of a previous study on diarrheagenic E. coli [29] carried
out in the same area. Indeed, resistance to this drug has been on the rise due to its low cost and
extensive use as prophylaxis to prevent HIV-opportunistic infections and other community-
acquired infections [31]. Surprisingly, in contrast to several reports which described an increase
in the prevalence of strains harboring ESBLs, we only found one ESBL-producing isolate [14],
[32]. We also detected fewer gentamicin and ampicillin-resistant strains than previous studies
carried out in other countries [23], [27],[33–34], including the aforementioned study in the
same center [29]. These results suggest that empirical treatment recommended by the World
Health Organization for chorioamnionitis [35] and neonatal sepsis and/or meningitis (ampicil-
lin plus an aminoglycoside, normally gentamicin) and postpartum endometritis [36] (clinda-
mycin or ampicillin plus gentamicin) could be effective.
In general, the isolates studied could not be considered as very virulent because of the low
prevalence of VFGs found compared to other studies [3],[23],[27],[37], particularly in regard
to the 43% of our isolates from Manhiça which did not encode any VFG. However, the pres-
ence of the hlyA gene, an indicator of virulence and the possible cause of intestinal and
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extraintestinal infections [37–38], the iutA gene, a siderophore, and the iucC gene, an aerobac-
tin, which plays a specific role in maternofetal infections [26], was significantly more frequent
in VEC isolates from Rabat than in those fromManhiça, suggesting that these isolates would
be major virulence determinants carriers. Similar to previous studies [27], iron transport sys-
tems were the virulence factors most frequently found in isolates from both sites. These systems
could be targets for future vaccination strategies in urinary tract infections (UTIs) [39]. Indeed,
the siderophore, iutA, and the yersiniabactin, fyuA, were significantly more frequently
observed among SXT-resistant compared to the susceptible isolates in Manhiça, contrary to
what was reported by Moreno et al. [40], indicating that in our case the selective pressure of
SXT had not effects in the virulence carriage of these strains.
Less than 15% of isolates from the two countries belonged to the B2 phylogroup, in contrast
to previous reports of more than 50% [23],[26–27]. The most predominant phylogroup in
Manhiça was E. This phylogroup is known for the well-recognized O157:H7, and these strains
are associated with the sharing of alleles with groups B1 and A [41], and the absence of viru-
lence factors, bacteriocins and antimicrobial resistance [42]. One quarter of the isolates from
Manhiça were non-typeable, since they could not be assigned to any phylogroup or indicated
the high variability of gene content due to the gain or loss of virulence genes [24]. This result
was similar to what described in a study analyzing uropathogenic E. coli isolates performed in
Iran [43] but differs from the results obtained by Clermont et al. [24], who reported that phylo-
grouping was not possible in less than 1% of the isolates studied. This fact has been related to
the variability found in phylogenetic group distribution according to several factors [18]. Phy-
logroup A was the most frequently detected in Rabat, being associated with a low number of
VFGs and commensal flora. However, it is not clear whether E. coli isolates should be defined
as commensal based entirely on the source and/or regarding the phylogenetic group since phy-
logroups A and B1 may cause extraintestinal infections in immunocompromised hosts at a spe-
cific time [44]. Taking all this information into account, the virulence of these VEC isolates
was low according to the phylogenetic group and the possession of VFGs compared with other
studies from East Japan [3], France [26], and Spain [23],[27], in which most of the strains stud-
ied belonged to group B2 and had a significant number of VFGs. However, in our study isolates
belonging to phylogroups B2 and D were more frequent among ampicillin-resistant isolates
while in other studies, non-B2 phylogroups were associated with resistant strains, albeit to
other antimicrobial agents [40].
One limitation of the present study is that it is focused on colonization rather than infection
and included only two hospitals from different sites of Africa, thereby not allowing extrapola-
tion of our results to LMICs. However, this is the first study to characterize VEC isolates from
pregnant women in these countries. Considering the involvement of VEC isolates in extrain-
testinal infections, our results may be helpful to develop strategies to prevent maternal and
neonatal infections. Furthermore, vaginal swabs have shown to be a good tool to guide proper
clinical management in women presenting PPROM in resource-limited sites where other more
complex microbiological methods are not viable [6].
In summary, VEC isolates from Rabat and Manhiça showed low virulence and antimicro-
bial resistance compared to isolates from developed countries suggesting that they are not
intrinsically ‘virulent clones’. However, the emergence of multidrug resistance, the plasticity of
the genome of E. coli isolates which allows the acquisition of virulence genes, the relationship
between disease severity and host factors, the vulnerability to infections presented by pregnant
women, and the lack of resources in LMICs must also be taken into account. Consequently,
continuous surveillance of the virulence and antimicrobial resistance patterns of these isolates
is needed, especially in areas with adverse socio-economic conditions.
Vaginal Escherichia coli in Morocco and Mozambique
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